Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects
Maria Pena, Javier Muriel, Miriam Saiz‐Rodríguez, Alberto M. Borobia, Francisco Abad‐Santos, Jesús Frías, Ana M. Peiró
Topics & Concepts
PharmacokineticsMedicinePharmacologyCYP2D6ImatinibPharmacotherapyCytochrome P450Internal medicineMyeloid leukemiaMetabolismChronic Myeloid Leukemia TreatmentsGastrointestinal Tumor Research and TreatmentMyeloproliferative Neoplasms: Diagnosis and Treatment